Skip to content

Clinical trials

Central Nervous System Diseases trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Country / region: Japan Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20111
20121
20142
20151
20161
20171
20181
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated5
Completed4
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Bayer1
Eisai Co., Ltd.1
Eisai Inc.1
Eli Lilly and Company1
Japan Cardiovascular Research Foundation1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Remedy Pharmaceuticals, Inc.1
Shire1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases11
Brain Diseases9
Nervous System Diseases8
Alzheimer Disease6
Dementia6
Mental Disorders6
Tauopathies6
Neurodegenerative Diseases5
Cognitive Dysfunction3
Delirium3

Trials

Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.